Arcturus Therapeutics Holdings
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ARCT and other ETFs, options, and stocks.About ARCT
Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF.
ARCT Key Statistics
Stock Snapshot
The current Arcturus Therapeutics Holdings(ARCT) stock price is $7.29, with a market capitalization of 209.97M. The stock trades at a price-to-earnings (P/E) ratio of -2.16.
On 2026-08-07, Arcturus Therapeutics Holdings(ARCT) stock moved within a range of $6.15 to $7.29. With shares now at $7.29, the stock is trading +18.5% above its intraday low and 0.0% below the session's peak.
Trading volume for Arcturus Therapeutics Holdings(ARCT) stock has reached 928K, versus its average volume of 376.6K.
Over the past 52 weeks, Arcturus Therapeutics Holdings(ARCT) stock has traded between a high of $24.17 and a low of $5.50.
Over the past 52 weeks, Arcturus Therapeutics Holdings(ARCT) stock has traded between a high of $24.17 and a low of $5.50.
ARCT News
...
Reports Q2 revenue $2.96M, consensus $3.12M. The company said, “We are encouraged by the continued progress of our ARCT-032 Phase 2 cystic fibrosis study, with...
Analyst ratings
77%
of 13 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.